Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armon, C.
Right arrow Articles by Mulder, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armon, C.
Right arrow Articles by Mulder, D. W.
NEUROLOGY 1991;41:1713
© 1991 American Academy of Neurology

When is an apparent excess of neurologic cases epidemiologically significant?

C. Armon, MD, J. R. Daubae, MD, P. C. O'Brien, PhD, L. T. Kurland, MD and D. W. Mulder, MD

Department of Neurology (Drs. Armon and Daube), the Section of Biostatistics (Dr. O'Brien), and the Section of Clinical Epidemiology (Dr. Kurland), Mayo Clinic and Mayo Foundation, Rochester, MN; Dr. Mulder is an emeritus member of the Department of Neurology.

To conserve clinical and public health resources, it is necessary to screen reports from the community of an excess or cluster of cases of chronic neurologic diseases for potential epidemiologic significance, ie, to identify those clusters that may have occurred owing to the operation of an underlying etiologic cause rather than to chance alone. Traditionally, the probability that such a cluster has occurred by chance within the reporting community is computed, ignoring the fact that many other similar communities have not reported a cluster. We propose a modified approach that takes this larger universe of communities into account, thereby raising the threshold for potential epidemiologic significance. As a result, the lowest value for the ratio of observed-to-expected cases that may be considered of epidemiologic significance should be increased by factors of 2 for small clusters (one to three expected cases), 1.5 for intermediate clusters (seven to 30 expected cases), and 1.3 for large clusters (60 to 90 expected cases). Consequently, case ascertainment and full field investigations can be reserved for only those reports that, if confirmed, would represent a cluster not due to chance alone. We illustrate this with a case from our own experience.

Address correspondence and reprint requests to Dr. L.T. Kurland, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

Supported in part by the Neuroepidemiologic Program Project Grant NS 17750 from the National Institute of Neurological and Communicative Disorders and Stroke.

Presented in part at the 114th annual meeting of the American Neurological Association, New Orleans, LA, September 1989.

Received February 22, 1991. Accepted for publication in final form May 8, 1991.




This article has been cited by other articles:


Home page
BrainHome page
A. Chio, G. Benzi, M. Dossena, R. Mutani, and G. Mora
Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players
Brain, March 1, 2005; 128(3): 472 - 476.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Kumar, S. M. Calne, M. Schulzer, E. Mak, Z. Wszolek, C. Van Netten, J. K. C. Tsui, A. J. Stoessl, and D. B. Calne
Clustering of Parkinson Disease: Shared Cause or Coincidence?
Arch Neurol, July 1, 2004; 61(7): 1057 - 1060.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. W. Haley
Excess incidence of ALS in young Gulf War veterans
Neurology, September 23, 2003; 61(6): 750 - 756.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A L Teixeira, F Cardoso, D P Maia, and M C Cunningham
Sydenham's chorea may be a risk factor for drug induced parkinsonism
J. Neurol. Neurosurg. Psychiatry, September 1, 2003; 74(9): 1350 - 1351.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
C. E. Sabel, P. J. Boyle, M. Loytonen, A. C. Gatrell, M. Jokelainen, R. Flowerdew, and P. Maasilta
Spatial Clustering of Amyotrophic Lateral Sclerosis in Finland at Place of Birth and Place of Death
Am. J. Epidemiol., May 15, 2003; 157(10): 898 - 905.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
S. D. Cook
REVIEW {blacksquare} : The Epidemiology of Multiple Sclerosis: Clues to the Etiology of a Mysterious Disease
Neuroscientist, May 1, 1996; 2(3): 172 - 180.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by AAN Enterprises, Inc.